Laura Antipov is a self-proclaimed “start-up junkie” with a passion for taking big ideas and translating them into clear, actionable plans. She has been in the biotech industry for 10 years, at three different early stage start-ups, always playing the same role: a “Jack-of-all-trades” problem solver. Laura joined Auron in January 2019; prior to that, she was the Director of Science at Riffyn, where she led collaborations with several global pharmaceutical companies and oversaw a breadth of drug development projects spanning exploratory research to process development. Prior to that, Laura helped build a drug discovery program from the ground up at Silver Creek Pharmaceuticals, a company she joined as employee #4. Her work at Silver Creek led to a clinical candidate currently in Phase 2 trials. Before joining industry, Laura performed postdoctoral research at Harvard Medical School where she studied protein structure/function relationships. Laura holds a PhD in Biological Chemistry from MIT and bachelor’s degrees in both Chemistry and Mathematics from the University of Missouri.
Laura lives in Watertown, MA, with her husband and two kids, where she splits her free time evenly between shuttling kids to activities and laundry.